AstraZeneca pledges further progress for healthcare environment in Vietnam

AstraZeneca pledges further progress for healthcare environment in Vietnam

AstraZeneca is strengthening local partnerships to unlock the power of science and improve access to healthcare. Atul Tandon, general director of AstraZeneca Vietnam, discussed with VIR’s Minh Anh about the vision and next steps.
AstraZeneca reinforces commitment to healthcare

AstraZeneca reinforces commitment to healthcare

Pharma giant AstraZeneca is solidifying its position as a pioneer in healthcare innovation in Vietnam.
Empowering innovation for Vietnam's sustainable healthcare

Empowering innovation for Vietnam's sustainable healthcare

VIR plans to host a healthcare conference on September 25, expecting to attract about 200 participants, including policymakers, international organisations, senior experts, and those from the business community.
AstraZeneca Vietnam deepens collaboration to enhance education and research

AstraZeneca Vietnam deepens collaboration to enhance education and research

AstraZeneca Vietnam is continuing its collaboration with the University of Medicine and Pharmacy of Ho Chi Minh City in medical education.
Nitin Kapoor of AstraZeneca Vietnam appointed MBE

Nitin Kapoor of AstraZeneca Vietnam appointed MBE

Nitin Kapoor, chairman of AstraZeneca Vietnam, has been appointed as a member of the Order of the British Empire.
AstraZeneca Vietnam dedicated to health

AstraZeneca Vietnam dedicated to health

AstraZeneca Vietnam has started the year by building on last year’s success with programmes that cater to improving livelihoods and enhancing healthcare.
AstraZeneca Vietnam chairman awarded Friendship Medal

AstraZeneca Vietnam chairman awarded Friendship Medal

Nitin Kapoor of AstraZeneca Vietnam was awarded the Friendship Medal by State President on December 4.
Health Innovation Network launched in Vietnam

Health Innovation Network launched in Vietnam

The Vietnam Young Physicians Association and AstraZeneca Vietnam hosted a ceremony in Ho Chi Minh City on November 19 to launch the Health Innovation Network.
AstraZeneca Vietnam partners with Can Tho city to improve health services

AstraZeneca Vietnam partners with Can Tho city to improve health services

AstraZeneca Vietnam and Can Tho city officials signed an agreement on November 14 to work together on health projects and create a lasting healthcare system.
AstraZeneca Vietnam and HSAACI enter cooperation agreement

AstraZeneca Vietnam and HSAACI enter cooperation agreement

AstraZeneca and the HSAACI unveiled a comprehensive strategic cooperation memorandum on October 2.
AstraZeneca Vietnam honoured with special BritCham award

AstraZeneca Vietnam honoured with special BritCham award

AstraZeneca Vietnam has received the British Chamber of Commerce's first-ever 50th Anniversary Recognition award.
MoH and AstraZeneca expand health partnership

MoH and AstraZeneca expand health partnership

AstraZeneca has taken its long-term partnership with Vietnam’s Ministry of Health to the next level for a resilient and healthy local population.
Multinational pharma groups keen on robust partnerships

Multinational pharma groups keen on robust partnerships

After making gains in 2022, multinational corporations will prioritise strengthening local partnerships to support their ambition of transforming the treatment landscape – but they are also pleading for further legal clarity.
AstraZeneca honoured in Vietnam’s top 100 best places to work 2022

AstraZeneca honoured in Vietnam’s top 100 best places to work 2022

AstraZeneca Vietnam has been recognised as one of Vietnam’s top 100 best places to work in 2022 for the fourth consecutive year.
AstraZeneca to increase early patient access to new medicines in Vietnam

AstraZeneca to increase early patient access to new medicines in Vietnam

Last week marked an important step in AstraZeneca’s journey in Vietnam. On his visit to Hanoi, Dr. John L. Perez, senior vice president of the Vaccines and Immune Therapies Unit at AstraZeneca, talked to VIR’s Bich Thuy about the company’s future ambition and ongoing efforts to increase Vietnamese patients’ early access to new medicines.
1 2